drugset / Trial / NCT03144518

Mood and Influenza Vaccine Response: A Feasibility Trial

NCT03144518 ↗

RandomizedParallel-groupQuadruple-blindBasic science

Summary

This study is a 2-arm, parallel, randomised controlled feasibility trial of a brief video intervention designed to induce positive affect (mood) in older adults in primary care settings prior to the receipt of influenza vaccination. Participants will be randomised into two conditions: experimental and active control. In the experimental condition, participants will view the approximately 15 minute long intervention video immediately prior to vaccination. In the active control condition, participants will view a matched video that is designed to be mood neutral. Pre-and-post positive affect levels will be assessed by self-report questionnaires. Immune response to the intervention and vaccination responses will be assessed in saliva and serum samples respectively. The objectives of the study are to assess the impact of the intervention on mood, immune function, and antibody response to influenza vaccination in older adults. This feasibility trial will also allow data collection on exploring recruitment, attrition, intervention engagement, and practicality of collecting clinical data available through electronic records to inform the design of a future definitive trial.

Timeline

Start
2017-09-01
Primary completion
2017-11-01
Completion
2018-05-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Northern Hemisphere Influenza Vaccine 2017/18 Vaccine — —

Indications

No indication recorded.